When Medrxiv, a site that hosts unpublished research manuscripts: calls preprints, in medical sciences launched in June 2019, things are stripped with a slow start.

"can take off slowly," John Inglis, co-founder of the server and executive director of Cold Spring Harbor Laboratory Press, told science at that time.

For the first months of its existence, that was true. "Medicine was a more conservative discipline," said Inglis, who is also co-founder of a preprint server for biology called Biorxiv, said in an interview. "We did not expect a huge and immediate uptake of prepress, because we needed to create confidence, we needed to create familiarity."

The pandemic changed things.

"In January 2020 we have 240 manuscripts," said Inglis. "In May 2020 we obtained 2,400".

A huge proportion of those were related to the pandemic, with an analysis by nature that suggests approximately two thirds. Between 17 and 30 percent of all research documents on Covid-19 have been preprinted, that same analysis showed. The use of the site at MedrXiv went from 64,000 pages per month at the end of 2019 to more than 10 million visits at the height of the pandemic.

The year 2020 was a year of banner to prepress. The presentations to magazines also increased during the pandemic, but as the public grew hungry new information about the virus, prepress captured public attention as never before.

Prepress servers such as Medrxiv and BiOXIV have basic railings against the ranish hazardous research, but they are generally remained away from evaluating the quality of the scholarship. In Medrxiv, founded by Harbor's laboratory of Cold Spring, Yale and the BMJ, presentations are examined by a team of "affiliates" volunteers in medical sciences, and the site has a rejection rate of approximately 10 to 20 by Hundred, Inglis said. The documents can be launched by not having adequate ethical reviews or containing too much identification of the patient, for example. Medrxiv also rejects the documents that have the potential to cause a generalized alarm, such as those who claim a substance is carcinogenic, with the thought that these documents diffuse better after peer review.

With the pandemic, the publication criteria are stricter. The site forbade the papers that were based purely on computer modeling, such as modeling the disease, extended or projected the value of therapeutics.

"We feel in silico was not enough," said Inglis. "The documents were often made by people who were frustrated to be prevented from doing their normal work, in their normal laboratories and were trying to make a useful contribution to the understanding of the pandemic."

Inside Greater Ed, some prepress documents, including those based, purely in modeling, have been influential in guide conversations. In June, two teachers in mathematics and economics modeled the spread of Covid-19 in a university environment, concluding that without any intervention, all students on a 20,000 campus would trap the virus before the end of the semester. Other tracked COVID-19 papers extend in small schools. Still other Preprint servers, such as Arxiv, a major site for mathematics and physics research, have chosen to continue housing that type of research.

Within science, the prepress have attracted some controversy. Supporters often argue that shared research before peer review accelerates the rate at which science can occur. Without sometimes long delay of peer review, other researchers can take advantage of the fastest findings.

Sometimes that acceleration is clear. For example, in June 2020, researchers from Great Britain recorded an article to Medrxiv that detail their research on the effect of corticosteroids in Covid-19, discovering that their use reduces deaths in hospitalized patients for Covid-19. Before the paper is published in Medrxiv, the specific corticosteroid in the study was only used at approximately 30 percent of patients, according to a study published in the American JOU

Image of How to find a teaching job in Universities in China
Rate and Comment
Image of Statement by Secretary Cardona on President Biden’s Nomination of Roberto J. Rodríguez
Statement by Secretary Cardona on President Biden’s Nomination of Roberto J. Rodríguez

Declaration of Cardona Secretary at the Nomination of President Biden of Roberto J. Rodríguez April 28, 2021 Contact: Press Office, (202) 401-1576,

Read more →

Login

 

Register

 
Already have an account? Login here
loader

contact us

 

Add Job Alert